News Headlines Article

Physician Payment Disclosure Under Health Care Reform

Pharmaceutical marketing has been an American health care issue from as early as the 1950s, when Senator Estes Kefauver first questioned the relationship between large marketing expenditures and high drug costs. Since then, the debate regarding drug marketing has continued, along with increased industry spending. Analysis has shown that, from 1996 to 2005, drug company marketing expenditures more than tripled, from $11.4 to $29.9 billion.